NeuroNews issue 48 – EU



  • With the UK Stroke Association continuing its push to make thrombectomy treatments more widely accessible, NeuroNews speaks to Sanjeev Nayak (Stoke-on-Trent, UK), Dileep Yavagal (Coral Gables, USA) and Michihiro Tanaka (Kamogawa, Japan) to gain global perspectives
  • “So, you want to be a principal investigator?” Diederik Dippel (Rotterdam, The Netherlands) offers his advice for doctors hoping to bridge the gap into clinical research
  • Insights around time to recanalisation versus number of passes in mechanical thrombectomy, new data on the impact of discontinuing dual antiplatelet therapy (DAPT) after flow diverter implantation, and much more from this year’s European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (7–9 September, Nice, France)
  • PROFILE: Shelley Renowden (Bristol, UK) discusses her career in interventional neuroradiology (INR), as well as important recent milestones and new frontiers in the field
  • NEUROMODULATION: High-definition transcranial direct current stimulation (tDCS) is associated with a statistically significant increase in the number of ventilator-free days among critically ill COVID-19 patients, as per the HD-RECOVERY randomised controlled trial (RCT)


Please enter your comment!
Please enter your name here